AEMD : Summary for Aethlon Medical, Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 33 mins

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.78+0.02 (+0.53%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.76
Bid3.70 x 100
Ask4.99 x 200
Day's Range3.75 - 3.81
52 Week Range3.55 - 9.09
Avg. Volume21,636
Market Cap30.1M
PE Ratio (TTM)-4.28
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research5 days ago

    AEMD: FDA Discussions Regarding U.S. Clearance Pathway

    Aethlon (AEMD) reported financial results for their fiscal third quarter 2017 (ending December 2016) and provided an operational update.  There were no meaningful surprises in the financial results relative to our expectations with the top-line ($0 A vs. $8k E), operating expenses ($1.2M A vs. $1.3M E), net loss ($1.2M A vs. $1.3M E) and EPS (-$0.15 A vs. -$0.16) E) all coming in just about exactly where we had modeled. Relative to the balance sheet, AEMD exited fiscal Q3 with $628k cash and equivalents.  They raised $288k and $578k (net) from the sale of equity (via ATM) and convertible notes, respectively, during the quarter.  Subsequent to quarter-end, AEMD raised an additional $256k (net) via the sale of 64k common shares @ $3.98/share average through their ATM program.  Aethlon raised ~$810k through the ATM program since the beginning of Q2 and there remains ~$11M still available.

  • PR Newswire10 days ago

    Aethlon Medical Announces Fiscal 2017 Third Quarter Results

    SAN DIEGO, Feb. 10, 2017 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a developer of immunotherapeutic technologies to combat infectious disease and cancer, today announced results for its fiscal ...

  • PR Newswire14 days ago

    Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017

    SAN DIEGO, Feb. 6, 2017 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it will host its Third Quarter Fiscal 2017 investor conference call and webcast on Friday, February 10, ...